Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis

Journal of the American Academy of Dermatology

Volumn 64, Issue 4, 2011, Pages 663-670

  Tey, Hong Liang ^a   Tan, Andy Soon Leong ^b   Chan, Yuin Chew ^c  

^a NATIONAL SKIN CENTRE   (Singapore)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GLENEAGLES HOSPITAL   (Singapore)

Author keywords

antifungal; griseofulvin; Microsporum; systemic; terbinafine; tinea capitis; Trichophyton

Indexed keywords

GRISEOFULVIN; TERBINAFINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CHILD; CONTROLLED STUDY; COUGHING; DERMATOPHYTE; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; HYPERTRANSAMINASEMIA; IMMUNOCOMPROMISED PATIENT; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; META ANALYSIS; MICROSPOROSIS; MICROSPORUM; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; RHINORRHEA; SYSTEMATIC REVIEW; TINEA CAPITIS; TREATMENT DURATION; TREATMENT RESPONSE; TRICHOPHYTON; TRICHOPHYTOSIS; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; GRISEOFULVIN; HUMANS; NAPHTHALENES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TINEA CAPITIS;

EID: 79952815643     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.02.048     Document Type: Article

References (19)

1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
2. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
3. Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children. N Z Med J 1998;111:55-7. (Pubitemid 28123997)
4. Haroon TS, Hussain I, Aman S, Nagi AH, Ahmad I, Zahid M, et al. A randomized double-blind comparative study of terbinafine and griseofulvin in tinea capitis. J Dermatolog Treat 1995;6:167-9.
5. Fuller LC, Smith CH, Cerio R, Marsden RA, Midgley G, Beard AL, et al. A randomized comparison of 4 weeks of terbinafine vs 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol 2001;144:321-7. (Pubitemid 32178813)
6. Lipozencic J, Skerlev M, Orofino-Costa R, Zaitz VC, Horvath A, Chouela E, et al. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol 2002;146:816-23. (Pubitemid 34539191)
7. Memisoglu HR, Erboz S, Akkaya S, Akan T, Aksungur VL, Ünal I, et al. Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis. J Dermatolog Treat 1999;10:189-93. (Pubitemid 29438079)
8. Cáceres-Ríos H, Rueda M, Ballona R, Bustamante B. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. J Am Acad Dermatol 2000;42:80-4. (Pubitemid 30470324)
9. Gupta KA, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 2001;18:433-8. (Pubitemid 33070714)
10. Elewski BE, Cáceres HW, DeLeon L, El Shimy S, Hunter JA, Korotkiy N, et al. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol 2008;59:41-54.
11. Bennett ML, Fleischer AB, Loveless JW, Feldman SR. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol 2000;17:304-9.
12. Gupta AK, Saunder DN, Shear NH. Antifungal agents: an overview, part II. J Am Acad Dermatol 1994;30:911-33.
13. Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992;43:259-84.
14. Agarwal K, Manas DM, Hudson M. Terbinafine and fulminant hepatic failure. N Engl J Med 1999;340:1292-3.
15. Perveze Z, Johnson MW, Rubin RA, Sellers M, Zayas C, Jones JL, et al. Terbinafine-induced hepatic failure requiring liver transplantation. Liver Transpl 2007;13:162-4. (Pubitemid 46099987)
16. Product Information: Lamisil, terbinafine. Novartis Pharmaceuticals Corp, East Hanover, NJ. (PI revised 11/2005).
17. Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics 2004;114:1312-5. (Pubitemid 41647694)
18. González U, Seaton T, Bergus G, Jacobson J, Martínez- Monzón C. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev 2007;(4):CD004685.
19. Bagyalakshmi R, Senthilvelan B, Therese KL, Murugusundram S, Madhavan HN. Application of polymerase chain reaction (PCR) and PCR based restriction fragment length polymorphism for detection and identification of dermatophytes from dermatological specimens. Indian J Dermatol 2008;53:15-20. (Pubitemid 351591615)